a year ago
CRL
AnalystsRoss MukenRoss Muken's Stock Forecasts
AnalystsRoss Muken
Analyst Ranking
Top 20%
#1083 out of 5510 analysts
Average Return
+14.69%
Win Rate
74%23 out of 31
Risk vs Reward
Poor
Good
Ross Muken's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Charles River Laboratories International IncCRL | +79.84% | $148.74 | $267.49 | 2025-08-08 - 2026-08-07 | Buy |
Charles River Laboratories International IncCRL | +69.42% | $164.24 | $278.26 | 2026-02-19 - 2026-09-11 | Buy |
Rite Aid CorpRADCQ | +61.83% | $40.60 | $15.50 | 2018-01-05 - 2019-01-04 | Sell |
Charles River Laboratories International IncCRL | +56.92% | $177.33 | $278.26 | 2025-10-03 - 2026-09-11 | Buy |
Charles River Laboratories International IncCRL | +56.66% | $177.62 | $278.26 | 2026-05-08 - 2026-09-11 | Buy |
Ross Muken Analyst Color
Get additional color on Ross Muken's coverage of popular stocks
Ross Muken's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Charles River Laboratories International IncCRL | 14 | Buy | $320.00 | +15.00% | Maintains | a day ago |
Icon PLCICLR | 7 | Buy | $180.00 | +6.31% | Maintains | 3 months ago |
Henry Schein IncHSIC | 8 | Hold | $70.00 | N/A | Maintains | a year ago |
Patterson Companies IncPDCO | 4 | Hold | $22.00 | N/A | Maintains | 2 years ago |
Agilent Technologies IncA | 10 | Hold | $130.00 | N/A | Maintains | 2 years ago |
Rite Aid CorpRADCQ | 2 | Sell | $30.00 | N/A | Initiates Coverage On | 9 years ago |
Cardinal Health IncCAH | 1 | Hold | $67.00 | N/A | Initiates Coverage On | 9 years ago |
Illumina IncILMN | 2 | Buy | $250.00 | N/A | Initiates Coverage On | 9 years ago |
Qiagen NvQGEN | 1 | Buy | $36.05 | N/A | Initiates Coverage On | 9 years ago |
Thermo Fisher Scientific IncTMO | 1 | Buy | $220.00 | N/A | Initiates Coverage On | 9 years ago |
Parexel International CorpPRXL | 2 | Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.